| scholarly article | Q13442814 |
| P50 | author | Kerry Rutter | Q60917733 |
| P2093 | author name string | Y Zhu | |
| H Su | |||
| B G Schroeder | |||
| C E Barry | |||
| J J De Voss | |||
| P2860 | cites work | Exochelin genes in Mycobacterium smegmatis: identification of an ABC transporter and two non-ribosomal peptide synthetase genes | Q48027677 |
| Universal chemical assay for the detection and determination of siderophores. | Q50905929 | ||
| The adverse effect of iron repletion on the course of certain infections | Q54956692 | ||
| The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis | Q71519595 | ||
| Transformation of mycobacterial species using hygromycin resistance as selectable marker | Q72372996 | ||
| Determination of the structure of exochelin MN, the extracellular siderophore from Mycobacterium neoaurum | Q73909517 | ||
| Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 | ||
| Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin | Q28486708 | ||
| The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages | Q28486738 | ||
| Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis | Q28486917 | ||
| Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog | Q28487133 | ||
| The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2 | Q28487181 | ||
| Characterization of exochelins of the Mycobacterium bovis type strain and BCG substrains | Q30656128 | ||
| Iron acquisition and metabolism by mycobacteria | Q33635173 | ||
| Analysis of the exochelin locus in Mycobacterium smegmatis: biosynthesis genes have homology with genes of the peptide synthetase family | Q33736702 | ||
| Assessment of immunity to mycobacterial infection with luciferase reporter constructs. | Q34001753 | ||
| Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis | Q34114738 | ||
| The effect of p-aminosalicyclic acid on iron transport and assimilation in mycobacteria | Q34646733 | ||
| Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall | Q34662814 | ||
| Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine | Q36361980 | ||
| Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis | Q36602879 | ||
| Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis | Q36603027 | ||
| Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis | Q36830155 | ||
| Iron and susceptibility to infectious disease | Q39940354 | ||
| A rapid and gentle method for the isolation of genomic DNA from mycobacteria | Q40407373 | ||
| Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches | Q40552842 | ||
| Role of mycobactin in the growth and virulence of tubercle bacilli | Q40878947 | ||
| Extracellular iron acquisition by mycobacteria: role of the exochelins and evidence against the participation of mycobactin | Q40881876 | ||
| The nonribosomal peptide synthetase HMWP2 forms a thiazoline ring during biogenesis of yersiniabactin, an iron-chelating virulence factor of Yersinia pestis | Q41485275 | ||
| Microbial iron transport: iron acquisition by pathogenic microorganisms | Q41691203 | ||
| Bacterial iron transport: mechanisms, genetics, and regulation. | Q41691207 | ||
| Isolation, purification and structure of exochelin MS, the extracellular siderophore from Mycobacterium smegmatis | Q41959357 | ||
| Tuberculosis and iron overload in Africa: a review. | Q46697838 | ||
| Dihydroaeruginoic acid synthetase and pyochelin synthetase, products of the pchEF genes, are induced by extracellular pyochelin in Pseudomonas aeruginosa | Q48003026 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| macrophage | Q184204 | ||
| P304 | page(s) | 1252-7 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages | |
| P478 | volume | 97 |
| Q28484764 | 4'-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo |
| Q35889537 | A Competitive Enzyme-Linked Immunosorbent Assay System for Adenylation Domains in Nonribosomal Peptide Synthetases |
| Q30672146 | A Hidden Markov Model for identifying essential and growth-defect regions in bacterial genomes from transposon insertion sequencing data |
| Q36950010 | A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. |
| Q52663859 | A comparison of Rv0559c and Rv0560c expression in drug-resistant Mycobacterium tuberculosis in response to first-line antituberculosis drugs. |
| Q27700114 | A covalent adduct of MbtN, an acyl-ACP dehydrogenase from Mycobacterium tuberculosis, reveals an unusual acyl-binding pocket |
| Q28487138 | A genetic locus required for iron acquisition in Mycobacterium tuberculosis |
| Q33965669 | A high-throughput screening fluorescence polarization assay for fatty acid adenylating enzymes in Mycobacterium tuberculosis |
| Q33940962 | A histone-like protein of mycobacteria possesses ferritin superfamily protein-like activity and protects against DNA damage by Fenton reaction. |
| Q60914335 | A low-carb diet for a high-octane pathogen |
| Q33283240 | A mechanism-based aryl carrier protein/thiolation domain affinity probe |
| Q44130148 | A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. |
| Q35163364 | A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis |
| Q90264836 | A reevaluation of iron binding by Mycobactin J |
| Q33503444 | A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis |
| Q37257062 | Adenylating enzymes in Mycobacterium tuberculosis as drug targets |
| Q35052626 | Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity |
| Q52934669 | Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. |
| Q35608100 | An unprecedented NADPH domain conformation in lysine monooxygenase NbtG provides insights into uncoupling of oxygen consumption from substrate hydroxylation |
| Q34263643 | Analyses of MbtB, MbtE, and MbtF suggest revisions to the mycobactin biosynthesis pathway in Mycobacterium tuberculosis |
| Q38830420 | Antibiotic resistance mechanisms in M. tuberculosis: an update |
| Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
| Q41912333 | Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes |
| Q57617771 | Antimycobacterial activity of rhodamine 3,4-HPO iron chelators against Mycobacterium avium: analysis of the contribution of functional groups and of chelator's combination with ethambutol |
| Q28487064 | Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain |
| Q33994536 | Assembly of aryl-capped siderophores by modular peptide synthetases and polyketide synthases |
| Q91790499 | Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB |
| Q37051347 | BacA, an ABC transporter involved in maintenance of chronic murine infections with Mycobacterium tuberculosis |
| Q37675898 | Bacterial manipulation of innate immunity to promote infection. |
| Q36797634 | Biogenetic diversity of cyanobacterial metabolites |
| Q46157158 | Biosynthesis of isonitrile lipopeptides by conserved nonribosomal peptide synthetase gene clusters in Actinobacteria. |
| Q38195645 | Biosynthesis of mycobacterial lipids by polyketide synthases and beyond |
| Q27675807 | Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosis |
| Q34033807 | Both Corynebacterium diphtheriae DtxR(E175K) and Mycobacterium tuberculosis IdeR(D177K) are dominant positive repressors of IdeR-regulated genes in M. tuberculosis |
| Q37273190 | CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids |
| Q40447683 | Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. |
| Q28487459 | Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc |
| Q35073550 | Characterization of a novel plasmid, pMAH135, from Mycobacterium avium subsp. hominissuis |
| Q34127364 | Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter |
| Q34028103 | Chemical scaffolds with structural similarities to siderophores of nonribosomal peptide-polyketide origin as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis |
| Q58697032 | Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity |
| Q30410820 | Comparative analyses of transport proteins encoded within the genomes of Mycobacterium tuberculosis and Mycobacterium leprae |
| Q37550518 | Comparative genome analyses of Mycobacterium avium reveal genomic features of its subspecies and strains that cause progression of pulmonary disease |
| Q35775243 | Comparative genomics between human and animal associated subspecies of the Mycobacterium avium complex: a basis for pathogenicity |
| Q34734487 | Comprehensive database of Chorismate synthase enzyme from shikimate pathway in pathogenic bacteria |
| Q53072956 | Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis. |
| Q36314798 | Control of cell wall assembly by a histone-like protein in Mycobacteria |
| Q33832359 | Conversion of Mycobacterium smegmatis to a pathogenic phenotype via passage of epithelial cells during macrophage infection |
| Q42048353 | Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis |
| Q42411754 | Crystallization and preliminary X-ray crystallographic analysis of MbtI, a protein essential for siderophore biosynthesis in Mycobacterium tuberculosis. |
| Q28487128 | CtpV: a putative copper exporter required for full virulence of Mycobacterium tuberculosis |
| Q34880579 | Curation, integration and visualization of bacterial virulence factors in PATRIC |
| Q33636507 | Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy |
| Q36681712 | Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043. |
| Q39955278 | Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins. |
| Q37000848 | Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents |
| Q33752240 | Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis |
| Q36335811 | Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis |
| Q57067336 | Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks? |
| Q91772570 | Differential determinants of virulence in two Mycobacterium tuberculosis Colombian clinical isolates of the LAM09 family |
| Q33716960 | Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients |
| Q57816272 | Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-Oxidase. |
| Q27676547 | Discovery of a Siderophore Export System Essential for Virulence of Mycobacterium tuberculosis |
| Q39136936 | Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence |
| Q34128847 | Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in mice |
| Q90484104 | Diverse Localization and Protein Binding Abilities of Glyceraldehyde-3-Phosphate Dehydrogenase in Pathogenic Bacteria: The Key to its Multifunctionality? |
| Q92659581 | Dual RNA-Seq of Mtb-Infected Macrophages In Vivo Reveals Ontologically Distinct Host-Pathogen Interactions |
| Q39612553 | Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308. |
| Q41927049 | Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery |
| Q34622456 | Expanding the results of a high throughput screen against an isochorismate-pyruvate lyase to enzymes of a similar scaffold or mechanism. |
| Q37257887 | Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies |
| Q51838999 | Exposure of Mycobacterium marinum to low-shear modeled microgravity: effect on growth, the transcriptome and survival under stress. |
| Q36314197 | Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum |
| Q89820535 | Functional Genomics Insights Into the Pathogenicity, Habitat Fitness, and Mechanisms Modifying Plant Development of Rhodococcus sp. PBTS1 and PBTS2 |
| Q36934583 | Functions and importance of mycobacterial extracellular vesicles |
| Q35830969 | Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds |
| Q43077484 | Genome sequencing of pathogenic Rhodococcus spp. |
| Q60933768 | Genotypic differences between strains of the opportunistic pathogen Corynebacterium bovis isolated from humans, cows, and rodents |
| Q60914347 | Getting the iron out |
| Q99625046 | Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection |
| Q92668628 | Heterogeneity in respiratory electron transfer and adaptive iron utilization in a bacterial biofilm |
| Q87412319 | Highly immunoreactive antibodies against the rHup-F2 fragment (aa 63-161) of the iron-regulated HupB protein of Mycobacterium tuberculosis and its potential for the serodiagnosis of extrapulmonary and recurrent tuberculosis |
| Q92059250 | Hybridization-based capture of pathogen mRNA enables paired host-pathogen transcriptional analysis |
| Q37515880 | IdeR is required for iron homeostasis and virulence in Mycobacterium tuberculosis |
| Q28486979 | Identification and characterization of a major cell wall-associated iron-regulated envelope protein (Irep-28) in Mycobacterium tuberculosis |
| Q36948605 | Identification of Quantitative Proteomic Differences between Mycobacterium tuberculosis Lineages with Altered Virulence |
| Q28486535 | Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis |
| Q34484222 | Identification of nocobactin NA biosynthetic gene clusters in Nocardia farcinica |
| Q54345232 | Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS. |
| Q28486472 | Identification of the Mycobacterium tuberculosis SUF machinery as the exclusive mycobacterial system of [Fe-S] cluster assembly: evidence for its implication in the pathogen's survival |
| Q34221919 | Immune interference in Mycobacterium tuberculosis intracellular iron acquisition through siderocalin recognition of carboxymycobactins |
| Q34332652 | Immune responses to intracellular bacteria. |
| Q61449782 | Immunity to the Dual Threat of Silica Exposure and |
| Q40763880 | Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections |
| Q47733388 | In vitro and intra-macrophage gene expression by Rhodococcus equi strain 103. |
| Q34095054 | In vivo veritas: the search for TB drug targets goes live |
| Q33565674 | Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine |
| Q27662071 | Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI) |
| Q34495944 | Inhibitors of the Salicylate Synthase (MbtI) from Mycobacterium tuberculosis Discovered by High‐Throughput Screening |
| Q35378227 | Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis |
| Q92899062 | Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA |
| Q34102811 | Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance |
| Q30494299 | Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway |
| Q36580730 | Intracellular innate resistance to bacterial pathogens. |
| Q36358981 | Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis |
| Q90559084 | IroT/MavN Is a Legionella Transmembrane Fe(II) Transporter: Metal Selectivity and Translocation Kinetics Revealed by in Vitro Real-Time Transport |
| Q38606667 | Iron Acquisition Mechanisms: Promising Target Against Mycobacterium tuberculosis |
| Q39601233 | Iron Acquisition in Mycobacterium avium subsp. paratuberculosis. |
| Q30804236 | Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake |
| Q92163260 | Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections? |
| Q33635173 | Iron acquisition and metabolism by mycobacteria |
| Q38337798 | Iron acquisition strategies in mycobacteria. |
| Q36631531 | Iron acquisition within host cells and the pathogenicity of Leishmania |
| Q34134803 | Iron and Mycobacterium tuberculosis infection |
| Q35022961 | Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes |
| Q38387424 | Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts |
| Q36913895 | Iron in infection and immunity |
| Q37376232 | Iron in intracellular infection: to provide or to deprive? |
| Q26860448 | Iron metabolism and the innate immune response to infection |
| Q46579770 | Iron modulates the replication of virulent Mycobacterium bovis in resting and activated bovine and possum macrophages. |
| Q35605944 | Iron, mycobacteria and tuberculosis |
| Q39017192 | Iron-regulated protein HupB of Mycobacterium tuberculosis positively regulates siderophore biosynthesis and is essential for growth in macrophages |
| Q43509450 | Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. |
| Q90737097 | Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents |
| Q42927455 | Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS) |
| Q28216197 | Life and death in a macrophage: role of the glyoxylate cycle in virulence |
| Q34007415 | Life on the inside: probing mycobacterium tuberculosis gene expression during infection |
| Q28486753 | Lipid composition and transcriptional response of Mycobacterium tuberculosis grown under iron-limitation in continuous culture: identification of a novel wax ester |
| Q28545076 | Lipidomic analysis links mycobactin synthase K to iron uptake and virulence in M. tuberculosis |
| Q35709328 | Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis |
| Q92704112 | Looking beyond Typical Treatments for Atypical Mycobacteria |
| Q41430032 | M. tuberculosis intramembrane protease Rip1 controls transcription through three anti-sigma factor substrates |
| Q42322422 | Mass spectral determination of phosphopantetheinylation specificity for carrier proteins in Mycobacterium tuberculosis |
| Q22122381 | Massive gene decay in the leprosy bacillus |
| Q36078970 | MavN is a Legionella pneumophila vacuole-associated protein required for efficient iron acquisition during intracellular growth |
| Q90223256 | Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities |
| Q37201260 | Mechanism and regulation of mycobactin fatty acyl-AMP ligase FadD33 |
| Q28487185 | Mechanistic analysis of Mycobacterium tuberculosis Rv1347c, a lysine Nepsilon-acyltransferase involved in mycobactin biosynthesis |
| Q28478251 | Metabolic regulation of mycobacterial growth and antibiotic sensitivity |
| Q28487095 | Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes |
| Q38935075 | MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria |
| Q41376285 | Models for antitubercular activity of 5â-O-[(N-Acyl)sulfamoyl]adenosines. |
| Q43796053 | Molecular approaches to tuberculosis |
| Q24296184 | Molecular mechanism of lipopeptide presentation by CD1a |
| Q35622988 | Molecular mechanisms of host-pathogen interaction: entry and survival of mycobacteria in macrophages. |
| Q38725050 | Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster |
| Q35907046 | Mycobacteria, metals, and the macrophage |
| Q28487139 | Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition |
| Q35564117 | Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages |
| Q55215619 | Mycobacterium abscessus subsp. massiliense mycma_0076 and mycma_0077 Genes Code for Ferritins That Are Modulated by Iron Concentration. |
| Q34125243 | Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS). |
| Q33975716 | Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine |
| Q35247912 | Mycobacterium tuberculosis DosR is required for activity of the PmbtB and PmbtI promoters under hypoxia |
| Q33774924 | Mycobacterium tuberculosis Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Functions as a Receptor for Human Lactoferrin. |
| Q51122851 | Mycobacterium tuberculosis Rv1474c is a TetR-like transcriptional repressor that regulates aconitase, an essential enzyme and RNA-binding protein, in an iron-responsive manner. |
| Q35145130 | Mycobacterium tuberculosis Rv3402c enhances mycobacterial survival within macrophages and modulates the host pro-inflammatory cytokines production via NF-kappa B/ERK/p38 signaling |
| Q35220629 | Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lipid synthesis |
| Q34435468 | Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin |
| Q34740822 | Mycobacterium tuberculosis can utilize heme as an iron source |
| Q28082718 | Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance |
| Q35145725 | Mycobacterium tuberculosis gene expression in macrophages |
| Q34137695 | Mycobacterium tuberculosis in the post-genomic age. |
| Q34213787 | Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence |
| Q82241804 | Mycobactin-mediated iron acquisition within macrophages |
| Q64273818 | Mycofactocin Is Associated with Ethanol Metabolism in Mycobacteria |
| Q33808523 | N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines |
| Q36200942 | Natural products as mediators of disease. |
| Q61858045 | New Chromane-Based Derivatives as Inhibitors of Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies |
| Q91795842 | New Quinolone-Based Thiosemicarbazones Showing Activity Against Plasmodium falciparum and Mycobacterium tuberculosis |
| Q37150326 | New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections |
| Q64071213 | New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents |
| Q36752164 | Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumannii |
| Q27007035 | Nonclassical T cells and their antigens in tuberculosis |
| Q34596427 | Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis |
| Q38397331 | Nucleoside analogs and tuberculosis: new weapons against an old enemy. |
| Q28487515 | One-step purification of 5-enolpyruvylshikimate-3-phosphate synthase enzyme from Mycobacterium tuberculosis |
| Q36558841 | Partial complementation of Sinorhizobium meliloti bacA mutant phenotypes by the Mycobacterium tuberculosis BacA protein |
| Q53928435 | Partial genome sequencing of Rhodococcus equi ATCC 33701. |
| Q34675486 | Participation of fad and mbt genes in synthesis of mycobactin in Mycobacterium smegmatis |
| Q37263859 | Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice. |
| Q46954996 | Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis |
| Q28476108 | Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo |
| Q40561516 | Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis. |
| Q51712137 | Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study. |
| Q37256486 | Purification of Legiobactin and importance of this siderophore in lung infection by Legionella pneumophila |
| Q42836641 | Purification, crystallization and preliminary X-ray studies of MbtN (Rv1346) from Mycobacterium tuberculosis |
| Q35589896 | Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents |
| Q35753354 | Recent advances towards identification of new drug targets for Mycobacterium tuberculosis |
| Q28486886 | Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis |
| Q34513719 | Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter. |
| Q37065759 | Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis |
| Q37643409 | Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition |
| Q35805487 | Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice |
| Q57038543 | Rule-based modelling of iron homeostasis in tuberculosis |
| Q43736212 | SREA is involved in regulation of siderophore biosynthesis, utilization and uptake in Aspergillus nidulans |
| Q33894015 | Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates |
| Q37571317 | Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling |
| Q36498319 | Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence. |
| Q44258710 | Serum iron profile and ELISA-based detection of antibodies against the iron-regulated protein HupB of Mycobacterium tuberculosis in TB patients and household contacts in Hyderabad (Andhra Pradesh), India |
| Q33658322 | Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages |
| Q24681774 | Siderophore-based iron acquisition and pathogen control |
| Q90739257 | Signaling Natural Products from Human Pathogenic Bacteria |
| Q30524145 | Single-cell elemental analysis of bacteria: quantitative analysis of polyphosphates in Mycobacterium tuberculosis |
| Q34211472 | Sleeping with the enemy: how intracellular pathogens cope with a macrophage lifestyle |
| Q37196170 | Small molecule inhibition of microbial natural product biosynthesis-an emerging antibiotic strategy |
| Q39255222 | Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis |
| Q34483911 | Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis |
| Q27661119 | Solution structure of Rv2377c-founding member of the MbtH-like protein family |
| Q36341884 | Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis |
| Q37055581 | Structural and Functional Characterization of Aerobactin Synthetase IucA from a Hypervirulent Pathotype of Klebsiella pneumoniae |
| Q28487072 | Structural and functional analysis of Rv3214 from Mycobacterium tuberculosis, a protein with conflicting functional annotations, leads to its characterization as a phosphatase |
| Q78232480 | Structure and Biosynthesis of Fimsbactins A-F, Siderophores fromAcinetobacter baumanniiandAcinetobacter baylyi |
| Q34916276 | Structure and membrane affinity of a suite of amphiphilic siderophores produced by a marine bacterium |
| Q27684461 | Structure, Biochemistry, and Inhibition of Essential 4′-Phosphopantetheinyl Transferases from Two Species of Mycobacteria |
| Q33746313 | Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters |
| Q37062702 | Subtractive hybridization reveals a type I polyketide synthase locus specific to Mycobacterium ulcerans |
| Q35546031 | Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. |
| Q36603702 | Syntheses and Biological Evaluations of Highly Functionalized Hydroxamate Containing and N-Methylthio Monobactams as Anti-Tuberculosis and β-Lactamase Inhibitory Agents |
| Q35650399 | Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis |
| Q36351333 | Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis |
| Q36341699 | Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis |
| Q34143574 | Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers |
| Q34459862 | Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site. |
| Q48139536 | Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol |
| Q37137597 | Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis |
| Q37375735 | Synthesis of dideoxymycobactin antigens presented by CD1a reveals T cell fine specificity for natural lipopeptide structures |
| Q91971713 | The ABC exporter IrtAB imports and reduces mycobacterial siderophores |
| Q28607074 | The Complete Genome Sequence of the Emerging Pathogen Mycobacterium haemophilum Explains Its Unique Culture Requirements |
| Q89104000 | The Impact of Dietary Transition Metals on Host-Bacterial Interactions |
| Q28487578 | The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages |
| Q36159650 | The Mycobacterium tuberculosis transcriptional landscape under genotoxic stress |
| Q31114739 | The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M. |
| Q42373929 | The crucial role of the Aspergillus fumigatus siderophore system in interaction with alveolar macrophages |
| Q28487146 | The crystal structure of Rv1347c, a putative antibiotic resistance protein from Mycobacterium tuberculosis, reveals a GCN5-related fold and suggests an alternative function in siderophore biosynthesis |
| Q38200693 | The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses |
| Q45091061 | The ferrous iron transporter FtrABCD is required for the virulence of Brucella abortus 2308 in mice |
| Q33455648 | The genetic requirements for fast and slow growth in mycobacteria |
| Q36396908 | The hydroxamate siderophore rhequichelin is required for virulence of the pathogenic actinomycete Rhodococcus equi |
| Q38449680 | The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis |
| Q33788460 | The iron-regulated iupABC operon is required for saprophytic growth of the intracellular pathogen Rhodococcus equi at low iron concentrations |
| Q34266438 | The many faces of host responses to tuberculosis |
| Q37117205 | The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages |
| Q35039359 | The nonredundant roles of two 4'-phosphopantetheinyl transferases in vital processes of Mycobacteria |
| Q37848852 | The professional phagocyte Dictyostelium discoideum as a model host for bacterial pathogens |
| Q28482080 | The promoter of Rv0560c is induced by salicylate and structurally-related compounds in Mycobacterium tuberculosis |
| Q30413938 | The reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulence |
| Q36319177 | The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth |
| Q35044795 | The role of iron in infections with intracellular bacteria |
| Q36336719 | The role of iron in pulmonary pathology |
| Q28486427 | The stringent response of Mycobacterium tuberculosis is required for long-term survival |
| Q28486666 | The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase |
| Q36472036 | The surprising diversity of lipid antigens for CD1-restricted T cells |
| Q40087615 | The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection |
| Q47215316 | The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action |
| Q28487339 | Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment |
| Q37218259 | Transcriptional and Physiological Changes during Mycobacterium tuberculosis Reactivation from Non-replicating Persistence |
| Q92352097 | Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle |
| Q35988766 | Tuberculosis - metabolism and respiration in the absence of growth |
| Q36729126 | Tuberculosis chemotherapy: recent developments and future perspectives |
| Q34974987 | Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy |
| Q57808855 | Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores |
| Q35336015 | UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLES. |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
| Q38053069 | Virulence factors of the Mycobacterium tuberculosis complex |
| Q31156691 | Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses |
| Q28486874 | ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response |
| Q34353950 | lbtA and lbtB are required for production of the Legionella pneumophila siderophore legiobactin |
| Q28486582 | p-Hydroxybenzoic acid synthesis in Mycobacterium tuberculosis |
Search more.